 Organophosphates
"Organophosphates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Carbon-containing phosphoric acid derivatives. Included under this heading are compounds that have CARBON atoms bound to one or more OXYGEN atoms of the P(=O)(O)3 structure. Note that several specific classes of endogenous phosphorus-containing compounds such as NUCLEOTIDES; PHOSPHOLIPIDS; and PHOSPHOPROTEINS are listed elsewhere.
| Descriptor ID |
D010755
|
| MeSH Number(s) |
D02.705.400
|
| Concept/Terms |
Phosphoric Acid Esters- Phosphoric Acid Esters
- Acid Esters, Phosphoric
- Esters, Phosphoric Acid
- Phosphates, Organic
- Organic Phosphates
|
Below are MeSH descriptors whose meaning is more general than "Organophosphates".
Below are MeSH descriptors whose meaning is more specific than "Organophosphates".
This graph shows the total number of publications written about "Organophosphates" by people in this website by year, and whether "Organophosphates" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 1 | 0 | 1 | | 2005 | 1 | 0 | 1 | | 2006 | 1 | 0 | 1 | | 2008 | 2 | 0 | 2 | | 2009 | 2 | 0 | 2 | | 2010 | 1 | 1 | 2 | | 2012 | 0 | 1 | 1 | | 2014 | 2 | 1 | 3 | | 2015 | 1 | 0 | 1 | | 2016 | 2 | 1 | 3 | | 2017 | 2 | 0 | 2 | | 2018 | 4 | 1 | 5 | | 2019 | 5 | 4 | 9 | | 2020 | 3 | 2 | 5 | | 2021 | 2 | 6 | 8 | | 2022 | 0 | 9 | 9 | | 2023 | 2 | 7 | 9 | | 2024 | 1 | 14 | 15 | | 2025 | 6 | 6 | 12 | | 2026 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Organophosphates" by people in Profiles.
-
Mann SC, Lykins D, Coyle RP, Witt MD, Kim EY, Macatangay B, Brown TT, Dionne JA, Alcaide M, Lahiri CD, Ramirez C, Dumond JB, D'Souza G, Cohen MH, Wilson TE, Kassaye S, Tien PC, Adedimeji AA, Ellison L, Brooks KM, Bushman LR, Anderson PL, MaWhinney S. In the Mismatch: Viral Suppression Despite Low Tenofovir-Diphosphate in Dried Blood Spots in the Multicenter AIDS Cohort Study/Women's Interagency HIV Study Combined Cohort. Clin Infect Dis. 2026 Apr 30; 82(4):575-582.
-
Starling AP, Li X, Ames JL, Barrett ES, Bastain TM, Buss C, Dabelea D, Dunlop AL, Ferrara A, Hedderson MM, Herbstman J, Kannan K, Karagas M, O'Connor TG, Oh J, Peterson AK, Romano ME, Sathyanarayana S, Schmidt RJ, Simhan HN, Strakovsky RS, Trasande L, Wadhwa PD, Zhao Q, Bennett DH, Buckley JP. Gestational exposure to organophosphate ester flame retardants and child growth in weight, height, and body mass index at age 2-10 years: the Environmental influences on Child Health Outcomes Program. Environ Res. 2026 Jun 01; 298:124229.
-
Gartland M, Wang X, Liao Q, Li B, Du F, Krystal M, Tenorio AR, Pierce A, Castillo-Mancilla JR. Exploring the impact of baseline and on-treatment variables on durability of responses to fostemsavir through weeks 96 and 192 in the phase 3 BRIGHTE study. HIV Med. 2026 Mar; 27(3):386-396.
-
Yu Y, Brooks KM, Doncel GF, Best BM, Marzinke MA, Mirochnick M, Anderson P, Myer L, Celum C, Heffron R, Coleman J, Davey DJ, Hendrix CW, Momper JD, Bies R, Scott RK. Development of a Semi-Mechanistic Population Pharmacokinetic Model for Predicting Tenofovir Disoproxil Fumarate and Tenofovir Alafenamide Exposure in Plasma and Cellular Matrices During Pregnancy and Postpartum. Clin Pharmacokinet. 2026 Jan; 65(1):133-148.
-
Schrott R, Ames JL, Barrett ES, Bennet DH, Croen LA, Geiger SD, Kannan K, Rivera-Nunez Z, Oh J, Peterson AK, Pilsner JR, Schmidt RJ, Starling AP, Zhu Y, Ladd-Acosta C. Prenatal organophosphate ester exposure and epigenetic changes at birth: a characterization of the methylome in the ECHO cohort. Environ Int. 2025 Nov; 205:109908.
-
Engel N, Sykes C, Schauer AP, Kashuba ADM, Anderson PL, Bushman LR, Cottrell ML. Interlaboratory comparison of a dried blood spot assay for antiretroviral adherence: implications for clinical application. J Antimicrob Chemother. 2025 Oct 03; 80(10):2727-2731.
-
Anderson PL, Coppinger C, Cottrell ML, Marzinke MA. Recommendations for Interpreting Intraerythrocytic Tenofovir Diphosphate and Emtricitabine Triphosphate for HIV-1 Preexposure Prophylaxis Adherence Assessment. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):162-169.
-
Mugwanya KK, Saina M, Mugo NR, MaWhinney S, Morrow M, Schaafsma TT, Donnell D, Glidden DV, Ngure K, Brown CE, Rechkina EA, Chohan BH, Wu L, Hill E, Koome E, Akelo N, Mbaire S, Morrison SA, Kibatha M, Njeru I, Muriithi M, Coppinger C, Bushman L, Baeten JM, Anderson PL. Adherence thresholds for emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis against HIV acquisition in cisgender women: A randomized directly observed dosing study. PLoS Med. 2025 Sep; 22(9):e1004732.
-
Antwi S, Yang H, Enimil A, Martyn-Dickens C, Dompreh A, Sly-Moore E, Bosomtwe D, Amissah AK, Ojewale O, Asiedu P, Appiah AF, Opoku T, Sarfo AD, Kusi-Amponsah I, Bushman LR, Ellison L, Anderson PL, Kwara A. Tenofovir diphosphate concentrations in dried blood spots predict future HIV suppression but not virologic failure in adolescents with HIV. AIDS. 2025 Sep 01; 39(11):1668-1671.
-
Oh J, Quirós-Alcalá L, Li X, Kannan K, Lyu W, Avalos LA, Barrett ES, Bastain TM, Buckley JP, Cintora P, Croen LA, Dunlop AL, Ghassabian A, Habre R, Herbstman JB, Hernandez-Castro I, Hertz-Picciotto I, Liang D, McEvoy CT, O'Connor TG, Sathyanarayana S, Schantz SL, Schmidt RJ, Schweitzer JB, Starling AP, Volk HE, Woodbury ML, Woodruff TJ, Zhao Q, Zhu Y, Bennett DH. Prenatal exposure to organophosphate ester flame retardants and behavioral outcomes in early childhood in the Environmental influences on Child Health Outcomes (ECHO) cohort. Environ Int. 2025 Aug; 202:109649.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|